Fluoxymesterone 10mg Tablets for sale

What is Halotestin 10mg Tablets?

Halotestin is an anabolic steroid with a very strong androgenic activity, derived from methyltestosterone. The clinical purpose of fluoxymesterone consisted originally in the treatment of male hypogenitalism, delayed puberty in men, and in the treatment of breastneoplasms in women. Buy Halotestin 10mg Tablets

Due to its specific fluoxymesterone is mainly used by athletes to enhance the power performance, muscle hardness and aggression without increasing the overall weight; it is used as well in box and other combat sports. In bodybuilding fluoxymesterone is used rarely, because it does not promote significant muscle bulking.

Fluoxymesterone does not aromatize and does not convert to estradiol; however, this is a very potent androgen. Female athletes should stay away from the drug.

Fluoxymesterone has an interesting feature: it activates erythropoiesis (production of red blood cells) and enhances the branching of the capillary network in muscles, and as result of improved blood supply significantly increases strength and endurance.

Halotestin is an anabolic steroid with a very strong androgenic activity, derived from methyltestosterone. The clinical purpose of fluoxymesterone consisted originally in the treatment of male hypogenitalism, delayed puberty in men, and in the treatment of breastneoplasms in women.

Due to its specific fluoxymesterone is mainly used by athletes to enhance the power performance, muscle hardness and aggression without increasing the overall weight; it is used as well in box and other combat sports. In bodybuilding fluoxymesterone is used rarely, because it does not promote significant muscle bulking.

Fluoxymesterone does not aromatize and does not convert to estradiol; however, this is a very potent androgen. Female athletes should stay away from the drug.

Fluoxymesterone has an interesting feature: it activates erythropoiesis (production of red blood cells) and enhances the branching of the capillary network in muscles, and as result of improved blood supply significantly increases strength and endurance.

Each HALOTESTIN tablet, for oral administration, contains 2 mg, 5 mg or 10 mg fluoxymesterone. Inactive ingredients: calcium stearate, corn starch, FD&C Yellow No. 5, lactose, sorbic acid, sucrose, tragacanth. In addition, the 2 mg tablet contains FD&C Yellow No. 6 and the 5 mg and 10 mg contain FD&C Blue No. 2.

Endogenous androgens are responsible for normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include growth and maturation of the prostate, seminal vesicles, penis, and scrotum; development of male hair distribution, such as beard, pubic, chest, and axillary hair; laryngeal enlargement, vocal cord thickening, and alterations in body musculature and fat distribution. Drugs in this class also cause retention of nitrogen, sodium, potassium, and phosphorus, and decreased urinary excretion of calcium. Androgens have been reported to increase protein anabolism and decrease protein catabolism. Nitrogen balance is improved only when there is sufficient intake of calories and protein.

Androgens are responsible for the growth spurt of adolescence and for eventual termination of linear growth, brought about by fusion of the epiphyseal growth centers. In children, exogenous androgens accelerate linear growth rates, but may cause disproportionate advancement in bone maturation. Use over long periods may result in fusion of the epiphyseal growth centers and termination of the growth process. Androgens have been reported to stimulate production of red blood cells by enhancing production of erythropoietic stimulation factor.

During exogenous administration of androgens, endogenous testosterone release is inhibited through feedback inhibition of pituitary luteinizing hormone (LH). At large doses of exogenous androgens, spermatogenesis may also be suppressed through feedback inhibition of pituitary follicle stimulating hormone (FSH).

Inactivation of testosterone occurs primarily in the liver.

The half-life of fluoxymesterone after oral administration is approximately 9.2 hours.

In the male—HALOTESTIN Tablets are indicated for Replacement therapy in conditions associated with symptoms of deficiency or absence of endogenous testosterone.

Primary hypogonadism (congenital or acquired) testicular failure due to cryptorchidism, bilateral torsion, orchitis , vanishing testis syndrome; or orchidectomy.

Hypogonadotropic hypogonadism (congenital or acquired)—idiopathic gonadotropin or LHRH deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation.

Delayed puberty, provided it has been definitely established as such, and is not just a familial trait.

In the female—HALOTESTIN Tablets are indicated for palliation of androgen-responsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal, or who have been proven to have a hormone- dependent tumor as shown by previous beneficial response to castration.

Known hypersensitivity to the drug

Males with carcinoma of the breast

Males with known or suspected carcinoma of the prostate gland

Women known or suspected to be pregnant

Patients with serious cardiac, hepatic or renal disease

Warnings

Hypercalcemia may occur in immobilized patients and in patients with breast cancer. If this occurs, the drug should be discontinued.

Prolonged use of high doses of androgens (principally the 17-α alkyl-androgens) has been associated with development of hepatic adenomas, hepatocellular carcinoma, and peliosis hepatis—all potentially life-threatening complications.

Cholestatic hepatitis and jaundice may occur with 17-α-alkyl-androgens. Should this occur, the drug should be discontinued. This is reversible with discontinuation of the drug.

Geriatric patients treated with androgens may be at an increased risk of developing prostatic hypertrophy and prostatic carcinoma although conclusive evidence to support this concept is lacking.